Kezar Life Sciences, Inc. (KZR)
7.29
0.00 (0.00%)
USD |
NASDAQ |
Sep 03, 16:00
Kezar Life Sciences Cash and Short Term Investments (Annual) : 71.88M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 71.88M |
| December 31, 2024 | 132.24M |
| December 31, 2023 | 201.37M |
| December 31, 2022 | 276.56M |
| December 31, 2021 | 208.36M |
| Date | Value |
|---|---|
| December 31, 2020 | 140.45M |
| December 31, 2019 | 78.21M |
| December 31, 2018 | 107.43M |
| December 31, 2017 | 51.03M |
| December 31, 2016 | 9.747M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| NovelStem International Corp. | 0.0003M |
| Brainstorm Cell Therapeutics, Inc. | 0.029M |
| Summit Therapeutics, Inc. | 713.76M |
| Protara Therapeutics, Inc. | 155.55M |
| Clene, Inc. | 5.189M |